MAPK7 and brain neoplasm: Given this and the noted high frequency of increased low-level ERK5 expression over normal brain tissue (Figure 4E), it would suggest that dysregulation of ERK5 within both early and late stage brain tumours may have a functional impact on tumour development and progression.